To identify disease-specific T cell changes that occur in Crohn's disease (CD), the T cell receptor BV repertoires of lamina propria lymphocytes (LPL) isolated from both the inflamed and "disease-inactive" colons of seven CD patients were compared by the quantitative PCR and DNA sequence analysis. It was observed that the BV repertoires of LPL isolated from the disease-active and disease-inactive parts of the colon from the same individual were very different. Furthermore, nearly all of the differences occurred in CD4 ϩ LPL, with very few differences in the CD8 ϩ population of LPL. Although the pattern of BV segments that was increased in disease-active tissue relative to disease-inactive tissue was different for all seven CD patients, there were several BV segments that increased uniformly in the disease-active tissue of all seven individuals. CDR3 length analysis and DNA sequencing of these BV segments revealed that in six of the seven CD patients there was a striking degree of oligoclonality that was absent from disease-inactive tissue of the same individual. These observations suggest that at least some of the inflammation in CD is the result of responses by CD4 ϩ T cells to specific antigens. 
Introduction
Crohn's disease (CD) 1 is a chronic inflammatory disease of the intestine (1) of unknown etiology. Various hypotheses have been proposed to explain the etiology and pathogenesis of CD, ranging from exposure to an infective agent to aberrant T cell regulation (2) (3) (4) (5) (6) (7) (8) (9) . Despite this lack of basic knowledge regarding the initiating event in CD, there is reason to believe that immunological mechanisms may explain the chronicity and relapse of CD (10, 11) . CD is frequently accompanied by alterations in the humoral and/or cellular immune system (12, 13) , and there is an increasing amount of evidence that at least part of the inflammation in CD is T cell mediated. The increased number of T cells expressing the activation markers 4F2, transferrin receptor, and IL-2 receptor in the intestinal lesions of CD suggests that T cells are responding to antigenic stimulation and contribute to the local inflammatory process (14) (15) (16) (17) (18) . This is supported by other studies demonstrating higher levels of IL-2 mRNA and an increased frequency of cells secreting IL-2 and IFN-␥ in actively inflamed CD tissue compared to sites of inactive disease (19) (20) (21) (22) (23) . Finally, recent studies suggest that CD is accompanied by changes in the T cell receptor (TCR) repertoire of LPL that occurs predominantly in the CD4 ϩ population (24) . Despite all of these studies, the nature of the stimulus that leads to activation of T cells in CD still remains undefined. Evidence for a restricted T cell response occurring in the lamina propria of CD patients would have important implications for the pathogenesis and treatment of the disease. Accordingly, we have analyzed the TCR repertoires of LPL from CD patients using several molecular techniques to determine whether there is any evidence of a restricted T cell response that would be suggestive of antigen-specific stimulation.
Methods
Patient specimens. Intestinal surgical resections were obtained from seven patients with CD. The diagnoses of CD were based on clinical, endoscopic, histopathologic, and radiologic criteria (25) . All specimens were from the colon and represented the first resection for all individuals. In all cases, tissue that was both grossly and histologically involved, as well as tissue that was histologically uninvolved, as determined independently by a pathologist, was used for analysis. The age, activity, and duration of disease, surgical indications, and medication of all seven patients are shown in Table I .
Cell isolation. Mononuclear cells from lamina propria were isolated by the method of Bull and Bookman (26), modified as previously described (24) . Briefly, colonic mucosa was cut into small pieces and incubated with DTT, followed by EDTA treatment. The EDTA treatment was repeated two times or until crypt epithelium was no longer seen under phase microscopy. The remaining mucosal tissue was then incubated in the presence of collagenase for 6-12 h, resulting in the dissociation of the lamina propria and the release of lymphocytes. Cell viability was Ͼ 90%. CD4 ϩ and CD8 ϩ cells were isolated using immunomagnetic beads conjugated with anti-CD4 and anti-CD8 mAbs as described previously, and were Ͼ 98% pure (27, 28) .
Amplification and quantitation of BV-specific RNA by PCR. BV repertoire analysis was performed by quantitative PCR (qPCR) using a modified procedure as previously described by us (28) . Briefly, total cel-lular RNA was isolated from positively selected CD4 ϩ and CD8 ϩ cells with RNAzol B (Biotecx Laboratories, Houston, TX) and cDNA was synthesized using reverse BC and AC primers as described (28) . BV-specific cDNA was then amplified with BV-specific primers and a 32 P-labeled BC nested primer as previously described (28) . As controls, a pair of 5 Ј AC forward and 3 Ј AC reverse primers was included in each reaction to specifically amplify a portion of AC RNA. The amplified products were electrophoresed on 8% polyacrylamide gels, dried, and exposed to x-ray film. Using the autoradiograms for alignment, the amplified AC and BV bands were excised from the gel and the amount of radioactivity incorporated was determined by liquid scintillation counting. This method of quantitation is as accurate as when a phosphorimager is used for quantitation (data not shown). To correct for differences caused by pipetting errors and efficiency of amplification in each well, the cpm in each BV band was normalized to the AC band. The relative amount of each BV was expressed as a percent of the total of the cpm incorporated in all 22 BV reactions after normalizing for AC cpm. Under these conditions, the amount of radioactivity incorporated into the AC and BV bands is roughly proportional to the amount of input RNA (28) . Furthermore, this modified procedure for qPCR analysis is highly reproducible and consistently gives Ͻ 15% variation when the same sample of RNA is repeatedly analyzed (28, 29) .
Determination of oligoclonality. Assessment of oligoclonality within individual BV segments was performed as described (30) . Total RNA (1-5 g) from selected CD4 ϩ T cells was converted to cDNA and amplified by qPCR as described above using BV-specific primers. An aliquot (1-2 l) of this product then served as the template for a second round of PCR using conditions that were identical to those described above, except that primer concentrations were reduced to 3 pmol per 100 l reaction mixture. After 15 cycles, 2-4 l of the radioactive product was loaded on a standard 6% acrylamide sequencing gel. After overnight exposure to x-ray film, BV segments of various CDR3 lengths were visualized as a series of bands 3 bp apart and quantitated on a phosphorimager (30) .
Cloning and sequencing PCR products. The PCR products of those BV segments that appeared to be oligoclonal were purified using Magic PCR preps DNA purification system (Promega, Madison, WI) and were cloned into the TA cloning vector (Novagen, Madison, WI). 30-50 colonies containing inserts were randomly selected, and the inserts were sequenced using an automated sequencer (Applied Biosystems, Inc., Foster City, CA). The sequences were analyzed using the Mac-Vector sequence analysis program (IBI-A Kodak Co., New Haven, CT).
Results
Comparisons of TCR repertoires of LPL from disease-active and "disease-inactive" tissue in CD. Previous studies from this laboratory in which the TCR repertoires of PBL and LPL within the same individual were compared had suggested that CD is accompanied by an alteration in the TCR repertoire of LPL that occurs predominantly in CD4 ϩ cells (24) . To confirm this observation in a more definitive way, the TCR repertoires of LPL from both the disease-active and disease-inactive portions of the colons of seven CD patients were compared to each other. Because of the limited number of T cells that could be obtained from these tissues, and the fact that mAb specific for many TCR BV families are not yet available, semiquantitative PCR using BV-specific oligonucleotide was the only method by which a comprehensive analysis of the TCR repertoire for both CD4 ϩ and CD8 ϩ cells could be accomplished. A comparison of the BV-specific TCR repertoires of LPL from the disease-active and adjacent disease-inactive portions of the colons of three of the seven individuals is shown in Fig. 1 ; the relative increase or decrease in frequency of the various BV segments in disease-active tissue vs. disease-inactive tissue is shown in schematic form for all seven patients in Table II . As can be seen, the TCR repertoires of LPL isolated from the disease-active and disease-inactive portions of the colons differed extensively for all seven patients. Indeed, in all seven patients, there were many instances in which there were two-fold or greater differences in the levels of specific BV segments between the disease-active and disease-inactive portions of the colon (indicated by double and triple arrows, Table II ). These extensive differences in repertoire were observed primarily in the CD4 ϩ population. Especially striking were the relative increases in BV11, 15, and 17 in the disease-active tissue of all seven patients, and in BV16 in six of the seven patients; in many cases, the increases were two-and three-fold. In addition, all seven patients showed significant ( Ͼ 50%) relative increases in the levels of BV13S2. In contrast, there was a striking similarity in the repertoires of CD8 ϩ cells, and even when there were differences between the disease-active and diseaseinactive tissues, they did not parallel those observed in the CD4 ϩ population. These differences between the repertoires of LPL from disease-active and disease-inactive colonic tissue, and the restriction of these differences, for the most part, to CD4
ϩ LPL cannot be attributed to either experimental error or sampling location; when a similar analysis and comparison was performed for LPL isolated from adjacent colonic sections derived from the same active lesion, no such extensive differences were observed in either the CD4 ϩ or CD8 ϩ populations (Table III) .
Determination of oligoclonality. To determine whether the increased levels in some of the BV segments in the disease-active tissue might be caused by expansion or activation of a restricted number of T cells, a method that we and others have previously described for the rapid detection of oligoclonality was used to compare LPL from the disease-active and diseaseinactive tissues of all seven CD patients (30) (31) (32) . This method, which separates PCR-amplified BV segments on the basis of their CDR3 size and is capable of detecting clonal populations at the 1-10% level, was used to analyze the joining region diversity and heterogeneity of all of the BV segments that were increased in disease-active tissue relative to disease-inactive tissue (see Methods). In all, 53 BV segments were analyzed in this fashion (Fig. 2) . Patterns that were characteristic of restricted heterogeneity and were unique to disease-active tissue were observed in at least 11 instances; in BV11 and BV16 of patient B, BV11 and BV15 of patient C, BV13S2 of patient D, BV16 of patient E, BV13S2, 15, and 17 of patient F, and BV2 and 16 of patient G (Fig. 2) . Although additional examples of apparent oligoclonality could be observed, these appeared, in general, to be the same for both disease-active and diseaseinactive tissue (e.g., BV14 in patient A and BV20 in patient C).
In some cases, the decrease in heterogeneity and indications of oligoclonality in the disease-active tissue were very striking. For example, in patient C, LPL isolated from the disease-active colon, showed only two bands in BV11 compared to LPL isolated from disease-inactive colon which showed the characteristic six or more bands consistent with extreme heterogeneity. An even more striking example of restricted heterogeneity was observed in BV15 of patient C, where essentially only a single intense band was observed in the disease-active tissue, suggesting a high degree of oligoclonality. In other cases, the decreases in heterogeneity were more modest (e.g., BV11 and BV16 of patient B, and BV13S2, 15, 17 of patient F). In one individual, patient A, there was no evidence of restricted heterogeneity unique to the disease-active tissue.
Sequences of expanded TCRBV segments. The differences in the CDR3 length patterns observed for LPL from diseaseactive and disease-inactive tissue suggested that their TCR repertoires might be different with respect to CDR3 size and sequence. Furthermore, as suggested by the limited number of bands in BV11 and BV15 in the disease-active tissue of patient C, expansion of a limited number of T cells appeared to have occurred in some cases. Accordingly, BV segments that displayed restricted heterogeneity in disease-active tissue and where an apparent oligoclonal band representing at least 45% of the radioactivity in that particular BV segment was observed (see Methods) were amplified by PCR and cloned. As controls, the same BV segment from the disease-inactive tissue was also amplified and cloned. Thus, for example, for patient B, PCR-amplified BV11 and BV16 segments from LPL isolated from both the disease-active and disease-inactive tissue were cloned, and a large number of clones from each were sequenced. Similarly, the BV11 and BV15 segments of patient C were cloned and sequenced. No BV segments were sequenced for patients A and F because the former did not display any evidence of restricted heterogeneity by CDR3 length analysis (Fig. 2) and the latter did not display sufficient evidence of oligoclonality to warrant sequence analysis at this time. In all, of the 11 BV segments that showed restricted heterogeneity unique to the disease-active tissue, 7 were analyzed by DNA sequencing.
The results of sequence analysis of these seven BV segments from five individuals (B, C, D, E, and G) are shown in Tables IV-VIII . This analysis revealed expansion of a limited number of TCR in all seven cases. In some cases, this expansion was very striking. For example, in patient C, two clones represented 87% of the entire BV11 repertoire in the diseaseactive tissue, but only 2% in the "disease-inactive" tissue, and one clone represented 92% of the entire BV15 repertoire in the disease-active tissue, but only 19% in the disease-inactive tissue (Table V) . Similarly, in patient B, a single clone represented 61 vs. 12% of the entire BV11 repertoire (Table IV) , in patient E, two clones represented 54 vs. 16% of the entire BV16 repertoire (Table VII) , and in patient G two clones represented 53 vs. 15% of the entire BV2 repertoire for diseaseactive and disease-inactive tissue (Table VIII) . In the other two cases (BV16 in patient B and BV13S2 in patient D), evidence of expansion was less striking although the dominant clones present in the disease-active tissue were completely absent from the disease-inactive tissue. Thus, in all seven cases representing five different patients, there was a clear difference in the distribution of TCR in disease-active and diseaseinactive tissue, as well as evidence of preferential expansion of a limited number of TCR in the disease-active tissue.
Discussion
Previous studies from this laboratory in which the TCR repertoires of LPL and PBL within the same individual were compared for both CD and control groups had suggested that in CD there is a dramatic change in the TCR repertoire of CD4 ϩ LPL. To confirm this observation and to determine whether the observed changes in the repertoire displayed restricted heterogeneity indicative of an antigen-specific response, the TCR repertoires of LPL isolated from both disease-active and disease-inactive colonic tissue of seven CD patients were compared. Disease-inactive tissue was independently defined by a pathologist as tissue that showed no gross or histological evidence of inflammation. By comparing disease-active and disease-inactive tissue within the same individual, we could eliminate the possibility that any observed differences in repertoire were caused by individual genetic differences or mode of ther- apy. Furthermore, since LPL from disease-active and diseaseinactive tissues were derived from adjacent surgical specimens, we minimized repertoire differences that might be caused by cellular compartmentalization, such as those we have previously documented for T cells from peripheral blood and the lamina propria compartment (24) . This was confirmed by our comparison of LPL isolated from two adjacent segments of disease-active tissue of several CD patients, where we observed very few differences in CDR3 length profiles (data not shown) and repertoire (Table III) . When the repertoires of LPL from disease-active and disease-inactive tissue were compared within the same individual, we observed major differences in the CD4 ϩ population for all seven CD patients ( Fig. 1 and Table II ). In contrast, the repertoires of CD8
ϩ LPL from the disease-active and disease-inactive tissue of the same individual were strikingly similar. These observations confirm our previous conclusion that CD is accompanied by repertoire changes that occur predominantly in CD4 ϩ LPL (24) . These studies also reveal that although each patient is characterized by a unique pattern of repertoire differences, there are several BV segments that uniformly increase in the disease-active tissue of all seven CD patients relative to disease-inactive tissue. For all seven CD patients, there were significant increases (Ͼ 50%) in the levels of BV11, 13S2, 15, and 17 (Table II) . In addition, BV16 increased in six of the seven patients. In many of these cases, the increases were two-or threefold (Table II) .
The increases in the relative levels of RNA encoding several different BV segments in the disease-active tissue relative to disease-inactive tissue suggested that there was a preferential activation and/or proliferation of T cells expressing these BV segments. To determine whether this preferential activation might be restricted to T cells expressing a small number of different receptors (i.e., oligoclonal), we used an assay that we have previously used to detect oligoclonality in PBL and LPL (30, 31) . This analysis revealed evidence of oligoclonality that was unique to the disease-active tissue of six of the seven patients; only in patient A was there no evidence of oligoclonality by this assay (Fig. 2) . Sequence analysis of BV segments that displayed restricted heterogeneity patterns unique to the disease-active tissue confirmed the CDR3 length analysis data; the TCR sequences present in disease-active tissue were distinct from those present in disease-inactive tissue, and there was evidence of selective expansion of a small number of T cells (Tables IV-VIII) . In a few cases, TCR that were greatly expanded in the disease-active tissue were also observed in the disease-inactive tissue, although at a much lower frequency, suggesting that even in disease-inactive tissue there is already a partial expansion of T cells expressing these receptors. It is very likely that continued activation and expansion of T cells bearing these receptors are responsible for much of the inflammation in the disease-active tissue, although it is not clear why these T cells should suddenly become activated. One possibility, which is suggested by the large increases in the levels of several BV segments in disease-active tissue relative to disease-inactive tissue, is activation by one or more "superantigens" that are known to activate polyclonal T cells in a BV-specific fashion (33, 34) . Although the polyclonality of these BV segments of individual A is consistent with a superantigen-like response, the extreme oligoclonality observed in some of the other patients argue against a superantigen-like response. It may be that both superantigens and antigen-specific responses contribute to the inflammation observed in CD. Alternatively, there may be several different etiologies for CD. Such a scenario, in which there are different etiologies leading to the same gross manifestations, have been proposed for other autoimmune diseases (35) (36) (37) , and are supported by animal models of inflammatory bowel disease where different defects in or insults to the immune system lead to diseases with grossly similar characteristics (38) (39) (40) (41) (42) (43) (44) (45) . Further analysis of the inflammatory response in additional CD patients may allow us to distinguish between these various models and provide a better understanding of the etiology of CD.
In summary, our data suggest that at least in some CD patients there is evidence of a highly restricted T cell response. It remains to be determined whether these T cells play a primary role in initiating the disease process or are secondary to the initial event. Nevertheless, our identification of selectively expanded T cells suggests that it may be possible to identify the antigen(s) responsible for much of the inflammation in CD, and opens the door to the possibility of therapy aimed at tolerizing the patient to these antigens.
